Bruker Future Growth
Future criteria checks 1/6
Bruker is forecast to grow earnings and revenue by 14.5% and 6.9% per annum respectively. EPS is expected to grow by 27.6% per annum. Return on equity is forecast to be 19.6% in 3 years.
Key information
14.5%
Earnings growth rate
27.6%
EPS growth rate
Life Sciences earnings growth | 18.3% |
Revenue growth rate | 6.9% |
Future return on equity | 19.6% |
Analyst coverage | Good |
Last updated | 19 Dec 2024 |
Recent future growth updates
Recent updates
Bruker's (NASDAQ:BRKR) Anemic Earnings Might Be Worse Than You Think
Nov 14Bruker: Still Challenged, Certainly Margins
Nov 02Earnings Tell The Story For Bruker Corporation (NASDAQ:BRKR)
Oct 25We Think Bruker (NASDAQ:BRKR) Is Taking Some Risk With Its Debt
Sep 10Bruker: Multiple Risks And Declining Returns On Capital Aren't Priced In
Aug 22Is It Too Late To Consider Buying Bruker Corporation (NASDAQ:BRKR)?
Jul 22Bruker Corporation's (NASDAQ:BRKR) Business Is Yet to Catch Up With Its Share Price
Jun 09Bruker: A Confusing Acquisition Spree
May 31Bruker's (NASDAQ:BRKR) Promising Earnings May Rest On Soft Foundations
May 09Bruker Corporation: An Aggressive Acquisition Strategy
Apr 24Bruker Offers Upside With Key Enabling Technologies For Future Bio-Pharma Research
Apr 11Calculating The Fair Value Of Bruker Corporation (NASDAQ:BRKR)
Jan 22There's Reason For Concern Over Bruker Corporation's (NASDAQ:BRKR) Price
Jan 08Should You Be Adding Bruker (NASDAQ:BRKR) To Your Watchlist Today?
Dec 26Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 3,850 | 479 | N/A | 326 | 9 |
12/31/2025 | 3,611 | 339 | 417 | 519 | 13 |
12/31/2024 | 3,350 | 220 | 124 | 273 | 13 |
9/30/2024 | 3,241 | 305 | 157 | 267 | N/A |
6/30/2024 | 3,120 | 352 | 168 | 273 | N/A |
3/31/2024 | 3,001 | 402 | 181 | 284 | N/A |
12/31/2023 | 2,965 | 427 | 243 | 350 | N/A |
9/30/2023 | 2,818 | 319 | 206 | 316 | N/A |
6/30/2023 | 2,715 | 319 | 201 | 342 | N/A |
3/31/2023 | 2,621 | 312 | 149 | 284 | N/A |
12/31/2022 | 2,531 | 297 | 145 | 274 | N/A |
9/30/2022 | 2,506 | 275 | 119 | 242 | N/A |
6/30/2022 | 2,476 | 274 | 114 | 196 | N/A |
3/31/2022 | 2,458 | 282 | 176 | 262 | N/A |
12/31/2021 | 2,418 | 277 | 190 | 282 | N/A |
9/30/2021 | 2,362 | 270 | 254 | 347 | N/A |
6/30/2021 | 2,264 | 238 | 312 | 405 | N/A |
3/31/2021 | 2,118 | 204 | 304 | 395 | N/A |
12/31/2020 | 1,988 | 158 | 235 | 332 | N/A |
9/30/2020 | 1,960 | 158 | 169 | 265 | N/A |
6/30/2020 | 1,970 | 165 | 140 | 235 | N/A |
3/31/2020 | 2,035 | 177 | 141 | 234 | N/A |
12/31/2019 | 2,073 | 197 | 140 | 213 | N/A |
9/30/2019 | 2,026 | 207 | 144 | 210 | N/A |
6/30/2019 | 1,972 | 189 | 124 | 185 | N/A |
3/31/2019 | 1,925 | 184 | 159 | 210 | N/A |
12/31/2018 | 1,896 | 180 | 191 | 240 | N/A |
9/30/2018 | 1,873 | 98 | 170 | 211 | N/A |
6/30/2018 | 1,842 | 92 | N/A | 219 | N/A |
3/31/2018 | 1,813 | 84 | N/A | 166 | N/A |
12/31/2017 | 1,766 | 79 | N/A | 154 | N/A |
9/30/2017 | 1,706 | 151 | N/A | 142 | N/A |
6/30/2017 | 1,664 | 161 | N/A | 142 | N/A |
3/31/2017 | 1,621 | 152 | N/A | 177 | N/A |
12/31/2016 | 1,611 | 154 | N/A | 131 | N/A |
9/30/2016 | 1,619 | 146 | N/A | 190 | N/A |
6/30/2016 | 1,621 | 111 | N/A | 208 | N/A |
3/31/2016 | 1,646 | 119 | N/A | 188 | N/A |
12/31/2015 | 1,624 | 102 | N/A | 229 | N/A |
9/30/2015 | 1,654 | 66 | N/A | 149 | N/A |
6/30/2015 | 1,677 | 60 | N/A | 108 | N/A |
3/31/2015 | 1,739 | 55 | N/A | 123 | N/A |
12/31/2014 | 1,809 | 57 | N/A | 114 | N/A |
9/30/2014 | 1,853 | 66 | N/A | 176 | N/A |
6/30/2014 | 1,872 | 77 | N/A | 201 | N/A |
3/31/2014 | 1,870 | 83 | N/A | 182 | N/A |
12/31/2013 | 1,839 | 80 | N/A | 145 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: BRKR's forecast earnings growth (14.5% per year) is above the savings rate (2.6%).
Earnings vs Market: BRKR's earnings (14.5% per year) are forecast to grow slower than the US market (15.3% per year).
High Growth Earnings: BRKR's earnings are forecast to grow, but not significantly.
Revenue vs Market: BRKR's revenue (6.9% per year) is forecast to grow slower than the US market (9.1% per year).
High Growth Revenue: BRKR's revenue (6.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: BRKR's Return on Equity is forecast to be low in 3 years time (19.6%).
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/19 22:39 |
End of Day Share Price | 2024/12/19 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Bruker Corporation is covered by 34 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Luke Sergott | Barclays |
Michael Ryskin | BofA Global Research |
Derik de Bruin | BofA Global Research |